Log in to search using one of your social media accounts:

 

E-cigarettes 'help thousands successfully quit smoking'

Conclusion Stopping smoking remains the best thing you can possibly do for your health. Anything that can help reduce the number of people who smoke is likely to have a good impact on health. But although this study found e-cigarette use was linked to an increase in successful quit attempts, there are a number of things to be aware of: Attempting to quit with e-cigarettes alone may not be as helpful as attempting to quit using an NHS stop smoking service. Getting support and help for a quit attempt is thought to increase your chances of success fourfold. You can use NHS services and e-cigarettes together if you wish. The study can't prove using e-cigarettes is the direct reason for the improved rate of quit attempts as other confounding factors may have been involved. Some of the study results were surprising – for example, the researchers calculated that the rise in the legal age for smoking from 16 to 18 was associated with a bigger increase in quitting success rates than you'd expect. This casts some doubt over the results. Questions remain about whether e-cigarettes are really safe. While there's still work to do on this, Public Health England estimates the aids are 95% safer than using tobacco cigarettes. The important thing if you're a smoker is to give yourself the best possible chance of stopping smoking for good.   Links To The Headlines E-cigarettes 'help more smokers quit'. BBC News, September 14 2016 E-cigarette...
Source: NHS News Feed - Category: Consumer Health News Tags: Lifestyle/exercise Medication Heart/lungs Cancer Source Type: news

Related Links:

ConclusionsInformational resources and decision aids may enhance patient‐doctor communication and help young survivors better understand risk and manage expectations surrounding short and longer‐term physical and emotional effects after surgery.
Source: Psycho-Oncology - Category: Cancer & Oncology Authors: Tags: PAPER Source Type: research
Findings based on assessment of the interactive iCanDecide tool
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Oncology, Surgery, Journal, Source Type: news
To monitor the incidence rates of cancers, AIDS, cardiovascular diseases, and other chronic or infectious diseases, some global, national, and regional reporting systems have been built to collect/provide population‐based data about the disease incidence. Such databases usually report daily, monthly, or yearly disease incidence numbers at the city, county, state, or country level, and the disease incidence numbers collected at different places and different times are often correlated, with the ones closer in place or time being more correlated. The correlation reflects the impact of various confounding risk factors, such...
Source: Statistics in Medicine - Category: Statistics Authors: Tags: RESEARCH ARTICLE Source Type: research
ConclusionsDue to multiple perceived barriers, patient-clinician conversations about lung cancer screening may fall short of guideline-recommended shared decision-making supported by a decision aid. Consequently, patients may be left uncertain about lung cancer screening ’s rationale, trade-offs, and process.
Source: Journal of General Internal Medicine - Category: Internal Medicine Source Type: research
CONCLUSION: Glucose transporter immunoreactivity is present in colorectal mucosa in controls and IBD patients. GLUT5 expression is also associated with lymphatic vessels. This novel finding aids in the characterization of lymphatic vasculature in IBD patients. PMID: 29467549 [PubMed - in process]
Source: World Journal of Gastroenterology : WJG - Category: Gastroenterology Authors: Tags: World J Gastroenterol Source Type: research
Blue Earth Diagnostics said that its Axumin (fluciclovine F-18) PET radiopharmaceutical...Read more on AuntMinnie.comRelated Reading: Blue Earth highlights Axumin clinical results at ASTRO Blue Earth touts Axumin reader training results Novel PET tracer aids recurrent prostate cancer patients Medicare coverage gets easier for oncologic PET tracers Blue Earth PET radiotracer IDs prostate cancer recurrence
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
Arterys, a San Francisco, California firm, won FDA clearance for its Arterys Oncology AI suite. The cleared software aids in finding lesions within CT images of the lungs (Lung AI) and in both CT and MRI when assessing the liver (Liver AI). It uses a...
Source: Medgadget - Category: Medical Devices Authors: Tags: Radiology Source Type: blogs
We report early impact of these sessions with patients/family/caregivers.
Source: Journal of Medical Imaging and Radiation Sciences - Category: Radiology Authors: Source Type: research
Conclusion Studies have pointed out that there is concern about high anal cancer and anal HPV infection rates. They also highlighted the importance of the screening procedure for anal cancer prevention through cytology associated, or not, with molecular HPV detection methods.
Source: Journal of Coloproctology - Category: Gastroenterology Source Type: research
The National Institute on Drug Abuse (NIDA) seeks licensing and/or co-development research collaborations for use of software for substance use disorders, behavior modification, and cancer patient care and pain management, etc. NIDA has developed software that permits real-time communication of patient-reported data and associated geolocation data. The software can be used in patient treatment or as a research tool for evaluating effectiveness of treatments.IC: NIDANIH Ref. No.: E-224-2017Advantages: Provides smart, secure bidirectional interconnection between enterprise systems and smartphones  Checks ...
Source: NIH OTT Licensing Opportunities - Category: Research Authors: Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Chantix | Health | Heart | HIV AIDS | International Medicine & Public Health | Legislation | Nicotine | Nicotine Replacement Therapy | Science | Smokers | Sports Medicine | Study